Angiogenesis in non-small cell lung cancer. A new target for therapy (Q35627784)

9 August 2017

1 reference

title

Angiogenesis in non-small cell lung cancer. A new target for therapy (English)

1 reference

9 August 2017

Tracy E Kim

1

1 reference

9 August 2017

John R Murren

series ordinal

2

1 reference

9 August 2017

publication date

1 January 2002

1 reference

Treatments in Respiratory Medicine

9 August 2017

published in

1 reference

9 August 2017

volume

1

1 reference

9 August 2017

issue

5

1 reference

9 August 2017

page(s)

325-338

1 reference

Angiogenesis during implantation, and placental and early embryonic development

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Novel mechanism for age-related macular degeneration: an equilibrium shift between the angiogenesis factors VEGF and PEDF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Angiogenesis in cancer, vascular, rheumatoid and other disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Endothelial proliferation in tumours and normal tissues: Continuous labelling studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Reciprocal paracrine interactions between tumour cells and endothelial cells: the 'angiogenesis progression' hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Role of integrins in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Requirement of vascular integrin alpha v beta 3 for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Urokinase-dependent adhesion loss and shape change after cyclic adenosine monophosphate elevation in cultured rat mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

The urokinase-type plasminogen activator system in cancer metastasis: A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Interference with the urokinase plasminogen activator system: a promising therapy concept for solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Matrix metalloproteinases: biologic activity and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Development of matrix metalloproteinase inhibitors in cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Isolation of a tumor factor responsible for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Primary structure of bovine brain acidic fibroblast growth factor (FGF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Vascular endothelial growth factor is a secreted angiogenic mitogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Interleukin-8 as a macrophage-derived mediator of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Stimulation and inhibition of angiogenesis by placental proliferin and proliferin-related protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Biological action of leptin as an angiogenic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Vascular permeability factor (VPF, VEGF) in tumor biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Structure and distribution of modules in extracellular proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Tumor angiogenesis: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Interferon alfa-2a therapy for life-threatening hemangiomas of infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Inhibition of endothelial cell proliferation by gamma-interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Cloning of the cDNA encoding human tissue inhibitor of metalloproteinases-3 (TIMP-3) and mapping of the TIMP3 gene to chromosome 22

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Cloning of the human tissue inhibitor of metalloproteinase-4 gene (TIMP4) and localization of the TIMP4 and Timp4 genes to human chromosome 3p25 and mouse chromosome 6, respectively

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Platelet factor 4 blocks the binding of basic fibroblast growth factor to the receptor and inhibits the spontaneous migration of vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

The 16K Fragment of Prolactin Specifically Inhibits Basal or Fibroblast Growth Factor Stimulated Growth of Capillary Endothelial Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Inhibition of angiogenesis in vivo by interleukin 12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Vasostatin, a calreticulin fragment, inhibits angiogenesis and suppresses tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

METH-1, a human ortholog of ADAMTS-1, and METH-2 are members of a new family of proteins with angio-inhibitory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Pigment epithelium-derived factor: a potent inhibitor of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Antiangiogenic activity of prostate-specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Antiangiogenic activity of the cleaved conformation of the serpin antithrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Troponin I is present in human cartilage and inhibits angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Thrombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Tissue inhibitors of matrix metalloproteinases in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Neovastat, a naturally occurring multifunctional antiangiogenic drug, in phase III clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Phase I and pharmacologic study of the specific matrix metalloproteinase inhibitor BAY 12-9566 on a protracted oral daily dosing schedule in patients with solid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Wide spectrum of antitumor activity of a neutralizing monoclonal antibody to human vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

The antiangiogenic agents SU5416 and SU6668 increase the antitumor effects of fractionated irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Thalidomide is an inhibitor of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Immunotherapeutic and antitumour potential of thalidomide analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Angiogenesis: role of calcium-mediated signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Prognostic significance of tumoral angiogenesis in completely resected late stage lung carcinoma (stage IIIA-N2). Impact of adjuvant therapies in a subset of patients at high risk of recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Measuring changes in human tumour vasculature in response to therapy using functional imaging techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Challenges for imaging angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Quantitative assessment of angiogenesis and tumor vessel architecture by computer-assisted digital image analysis: effects of VEGF-toxin conjugate on tumor microvessel density

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Quantitative analysis of angiogenesis using confocal laser scanning microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Clinical implications of circulating angiogenic factors in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Development of target-based antineoplastic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Results of single and repeat dose studies of the oral matrix metalloproteinase inhibitor marimastat in healthy male volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

A Clinical Trial Design Avoiding Undue Placebo Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Randomized discontinuation trials: Utility and efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Quantitation and prognostic value of breast cancer angiogenesis: Comparison of microvessel density, Chalkley count, and computer image analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Granulocyte- and granulocyte– macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Relation of neovascularisation to metastasis of non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

Angiogenesis as a Prognostic Indicator of Survival in Non-Small-Cell Lung Carcinoma: a Prospective Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256626

21 January 2018

Identifiers

DOI

10.1007/BF03256626

1 reference

9 August 2017

1 reference